Works matching IS 15747891 AND DT 2022 AND VI 16 AND IP 6

Results: 11

microRNA-99a-5p induces cellular senescence in gemcitabine-resistant bladder cancer by targeting SMARCD1.

Published in:

Molecular Oncology, 2022, v. 16, n. 6, p. 1329, doi. 10.1002/1878-0261.13192

By:

Motoki Tamai;
Shuichi Tatarano;
Shunsuke Okamura;
Wataru Fukumoto;
Issei Kawakami;
Yoichi Osako;
Takashi Sakaguchi;
Satoshi Sugita;
Masaya Yonemori;
Yasutoshi Yamada;
Masayuki Nakagawa;
Hideki Enokida;
Hirofumi Yoshino

Publication type:

Article

Ex vivo drug sensitivity screening in multiple myeloma identifies drug combinations that act synergistically.

Published in:

Molecular Oncology, 2022, v. 16, n. 6, p. 1241, doi. 10.1002/1878-0261.13191

By:

Giliberto, Mariaserena;
Thimiri Govinda Raj, Deepak B.;
Cremaschi, Andrea;
Skånland, Sigrid S.;
Gade, Alexandra;
Tjønnfjord, Geir E.;
Schjesvold, Fredrik;
Munthe, Ludvig A.;
Taskén, Kjetil

Publication type:

Article

A new function for the serine protease HtrA2 in controlling radiation-induced senescence in cancer cells.

Published in:

Molecular Oncology, 2022, v. 16, n. 6, p. 1365, doi. 10.1002/1878-0261.13187

By:

Hammer, Liat;
Levin-Salomon, Vered;
Yaeli-Slonim, Naama;
Weiss, Moria;
Dekel-Bird, Naama P.;
Olender, Tsviya;
Porat, Ziv;
Winograd-Katz, Sabina;
Savidor, Alon;
Levin, Yishai;
Bialik, Shani;
Geiger, Benjamin;
Kimchi, Adi

Publication type:

Article

miR-200a/b/-429 downregulation is a candidate biomarker of tumor radioresistance and independent of hypoxia in locally advanced cervical cancer.

Published in:

Molecular Oncology, 2022, v. 16, n. 6, p. 1402, doi. 10.1002/1878-0261.13184

By:

Nilsen, Anja;
Hillestad, Tiril;
Skingen, Vilde E.;
Aarnes, Eva-Katrine;
Fjeldbo, Christina S.;
Hompland, Tord;
Sandø Evensen, Tina;
Stokke, Trond;
Kristensen, Gunnar B.;
Grallert, Beata;
Lyng, Heidi

Publication type:

Article

p53 mutations define the chromatin landscape to confer drug tolerance in pancreatic cancer.

Published in:

Molecular Oncology, 2022, v. 16, n. 6, p. 1259, doi. 10.1002/1878-0261.13161

By:

Zampieri, Carlotta;
Panatta, Emanuele;
Corbo, Vincenzo;
Mauriello, Alessandro;
Melino, Gerry;
Amelio, Ivano

Publication type:

Article

FGF7--FGFR2 autocrine signaling increases growth and chemoresistance of fusion-positive rhabdomyosarcomas.

Published in:

Molecular Oncology, 2022, v. 16, n. 6, p. 1272, doi. 10.1002/1878-0261.13145

By:

Milton, Christopher I.;
Selfe, Joanna;
Aladowicz, Ewa;
Man, Stella Y. K.;
Bernauer, Carolina;
Missiaglia, Edoardo;
Walters, Zoë S.;
Gatz, Susanne A.;
Kelsey, Anna;
Generali, Melanie;
Box, Gary;
Valenti, Melanie;
de Haven-Brandon, Alexis;
Galiwango, David;
Hayes, Angela;
Clarke, Matthew;
Izquierdo, Elisa;
Gonzalez De Castro, David;
Raynaud, Florence I.;
Kirkin, Vladimir

Publication type:

Article

PELI1 promotes radiotherapy sensitivity by inhibiting noncanonical NF-κB in esophageal squamous cancer.

Published in:

Molecular Oncology, 2022, v. 16, n. 6, p. 1384, doi. 10.1002/1878-0261.13134

By:

Dongfang Dai;
Hongping Zhou;
Li Yin;
Fei Ye;
Xiao Yuan;
Tao You;
Xiaohui Zhao;
Weiguo Long;
Deqiang Wang;
Xia He;
Jifeng Feng;
Deyu Chen

Publication type:

Article

Lung cancer cells expressing a shortened CDK16 3'UTR escape senescence through impaired miR-485-5p targeting.

Published in:

Molecular Oncology, 2022, v. 16, n. 6, p. 1347, doi. 10.1002/1878-0261.13125

By:

Qi Jia;
Baiyun Xie;
Zhaozhao Zhao;
Leihuan Huang;
Gang Wei;
Ting Ni

Publication type:

Article

Intrinsic and acquired drug resistance to LSD1 inhibitors in small cell lung cancer occurs through a TEAD4-driven transcriptional state.

Published in:

Molecular Oncology, 2022, v. 16, n. 6, p. 1309, doi. 10.1002/1878-0261.13124

By:

Wen Yan;
Chi-Yeh Chung;
Tao Xie;
Ozeck, Mark;
Nichols, Timothy C.;
Frey, Jessica;
Udyavar, Akshata R.;
Sharma, Shikhar;
Paul, Thomas A.

Publication type:

Article

A novel anti-c-Kit antibody--drug conjugate to treat wild-type and activating-mutant c-Kit-positive tumors.

Published in:

Molecular Oncology, 2022, v. 16, n. 6, p. 1290, doi. 10.1002/1878-0261.13084

By:

Jin-Ock Kim;
Kwang-Hyeok Kim;
Eun Ji Baek;
Bomi Park;
Min Kyung So;
Byoung Joon Ko;
Han-Jik Ko;
Sang Gyu Park

Publication type:

Article

Desmoglein-2 expression is an independent predictor of poor prognosis patients with multiple myeloma.

Published in:

Molecular Oncology, 2022, v. 16, n. 6, p. 1221, doi. 10.1002/1878-0261.13055

By:

Ebert, Lisa M.;
Vandyke, Kate;
Johan, M. Zahied;
DeNichilo, Mark;
Lih Y. Tan;
Min, Kay K. Myo;
Weimann, Benjamin M.;
Ebert, Brenton W.;
Pitson, Stuart M.;
Zannettino, Andrew C. W.;
Wallington-Beddoe, Craig T.;
Bonder, Claudine S.

Publication type:

Article